Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 2229Neoplasms 2031Lung Neoplasms 1094Colorectal Neoplasms 1033Prostatic Neoplasms 892Carcinoma, Non-Small-Cell Lung 751Carcinoma, Hepatocellular 672Stomach Neoplasms 606Pancreatic Neoplasms 599Head and Neck Neoplasms 433Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Urinary Bladder Neoplasms 289Leukemia, Myeloid, Acute 276Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 251Disease 241Recurrence 225Glioma 217Carcinoma, Renal Cell 207

Interventions

nimotuzumab 1Chemotherapy, Adjuvant 1Chemoradiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Resectable Pancreatic Cancer × Clear all
NCT06363084 2024-04-12

A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Ruijin Hospital

Completed
64 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Unknown
400 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡